Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.38 |
| ▸ | MMP3 | P08254 | 1/20 | 0.38 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7107009 | 0.97 | ALDH1A1 (0.50) | ALDH1A1HSD17B10ALOX15MAPK1RAB9A | |
| SCHEMBL4580148 | 0.82 | ALDH1A1 (0.46) | ALDH1A1HSD17B10MAPK1HPGDTDP1 | |
| SCHEMBL2718825 | 0.80 | ABL1 (0.43) | ALDH1A1KDM4EHPGDMAPTCYP3A4 | |
| Biphenyl SCHEMBL27643334 | 0.72 | ALDH1A1 (0.82) | ALDH1A1HSD17B10MAPK1RAB9ANPC1 | |
| SCHEMBL30108088 | 0.71 | ALDH1A1 (1.00) | ALDH1A1HSD17B10MAPK1RAB9ANPC1 | |
| Biphenyl SCHEMBL1358618 | 0.71 | ALDH1A1 (1.00) | ALDH1A1HSD17B10MAPK1RAB9ANPC1 | |
| Biphenyl SCHEMBL29008551 | 0.71 | ALDH1A1 (1.00) | ALDH1A1HSD17B10MAPK1RAB9ANPC1 | |
| Biphenyl SCHEMBL2548048 | 0.71 | ALDH1A1 (1.00) | ALDH1A1HSD17B10MAPK1RAB9ANPC1 | |
| Biphenyl SCHEMBL28890607 | 0.71 | ALDH1A1 (1.00) | ALDH1A1HSD17B10MAPK1RAB9ANPC1 | |
| Biphenyl SCHEMBL164 | 0.71 | ALDH1A1 (1.00) | ALDH1A1HSD17B10MAPK1RAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1059 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4612298-A1 | BCMA VH-ONLY CARS | Dana-Farber Cancer Institute, Inc. (US) | 2025-09-10 | — | — | EP | claimed |
| CN-120040347-A | Preparation method of oxcarbazepine impurity | 重庆圣华曦药业股份有限公司 | 2025-05-27 | — | — | CN | claimed |
| CN-119798163-A | New continuous carbamazepine preparation process | 浙江工业大学 | 2025-04-11 | — | — | CN | claimed |
| CN-117050016-B | Preparation method of carbamazepine intermediate | 江苏慈星药业有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-119264051-A | Preparation method of key intermediate of dibenzoazepine medicines and intermediate thereof | 浙江中科创越药业有限公司 | 2025-01-07 | — | — | CN | claimed |
| CN-116284148-B | Asymmetric catalyst of macromolecule supported metal rhodium and synthetic method thereof | 哈尔滨工业大学（深圳） | 2024-12-24 | — | — | CN | claimed |
| CN-118638054-A | Comprehensive synthesis method of iminostilbene and intermediate thereof | 湖北华洲药业有限公司 | 2024-09-13 | — | — | CN | claimed |
| CN-118388406-A | Double-response iminostilbene fluorescent probe as well as preparation method and application thereof | 天津大学 | 2024-07-26 | — | — | CN | claimed |
| CN-118388456-A | Iminostilbene fluorescent probe for detecting hydrazine hydrate and preparation method and application thereof | 天津大学 | 2024-07-26 | — | — | CN | claimed |
| US-20240216316-A1 | DIHOMO-GAMMA LINOLENIC ACID (DGLA) IS A NOVEL SENOLYTIC | BUCK INST RES AGING (US) | 2024-07-04 | — | — | US | claimed |
| WO-1994012621-A1 | ENHANCEMENT OF ENZYME REACTIONS | NOVO NORDISK (DK) | 1994-06-09 | — | — | WO | claimed |
| EP-0546563-A2 | Complex crystal | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 1993-06-16 | — | — | EP | claimed |
| US-5110923-A | METHOD FOR PREPARING 5-CHLOROCARBONYL-5H-DIBENZ(B,F)AZEPINE | ARZNEIMITTELWERK DRESDEN GMBH (DE) | 1992-05-05 | — | — | US | claimed |
| EP-0237952-B1 | PROCESS FOR THE PREPARATION OF 5H-DIBENZO-(B, F)-AZEPINE | ORION-YHTYMÄ OY FERMION (FI) | 1991-10-30 | — | — | EP | claimed |
| CN-1039018-A | N, the preparation method of N-(the inferior second triolefin of dibenzo) urea | CIBA GEIGY AG (CH) | 1990-01-24 | — | — | CN | claimed |
| US-4847374-A | Process for the manufacture of N,N-(Dibenzohexatrienylene)ureas | CIBA-GEIGY CORPORATION (US) | 1989-07-11 | — | — | US | claimed |
| US-4758554-A | Method for treating convulsions and epilepsy with organic copper compounds | INTERNATIONAL COPPER RESEARCH ASSOCIATION (US) | 1988-07-19 | — | — | US | claimed |
| US-4699634-A | SEMIPERMEABLE MEMBRANES | THE STANDARD OIL COMPANY (US) | 1987-10-13 | — | — | US | claimed |
| EP-0237952-A1 | Process for the preparation of 5H-Dibenzo-(b, f)-azepine | ORION-YHTYMÄ OY FERMION (FI) | 1987-09-23 | — | — | EP | claimed |
| EP-0063525-A1 | Dibenzazepine tetracyclic derivatives, process for their preparation and pharmaceutical compositions containing them | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1982-10-27 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240216316-A1 | DIHOMO-GAMMA LINOLENIC ACID (DGLA) IS A NOVEL SENOLYTIC | DAGLA, DAGLB, MGLL | ALDH1A1 978/4885HSD17B10 860/4885ALOX15 29/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.